Skip to content
Just-Evotec Biologics
Just-Evotec BiologicsJust-Evotec Biologics
  • About
    • Our Story
    • Leadership
    • Partnership
  • GMP MANUFACTURING
  • Solutions
    • J.DESIGN
      • Humanoid Antibody Library (J.HAL)
      • GMP Manufacturing (J.POD)
  • News
    • Events
    • Press
    • Publications
      • Drug Discovery Update (DDup) journal
      • Scientific journals
      • Trade journals
    • Posters
    • Webinars
    • White Papers & Application Notes
  • Careers
  • Contact
  • Evotec
Search:
  • About
    • Our Story
    • Leadership
    • Partnership
  • GMP MANUFACTURING
  • Solutions
    • J.DESIGN
      • Humanoid Antibody Library (J.HAL)
      • GMP Manufacturing (J.POD)
  • News
    • Events
    • Press
    • Publications
      • Drug Discovery Update (DDup) journal
      • Scientific journals
      • Trade journals
    • Posters
    • Webinars
    • White Papers & Application Notes
  • Careers
  • Contact
  • Evotec

News

View allDDup 11PostersPress ReleasePublicationsScientific journalsTrade journalsWebinarsWhite Papers & Application Notes

Just – Evotec Biologics Enters Into Multi-Year Collaboration With MSD Around Facility of the Future

Press ReleaseJanuary 14, 2020

• MSD to gain access to manufacturing know-how within Just – Evotec Biologics’ J.POD® facility (“Facility of the future”) • Multi-year collaboration in form of…

Learn more

Just – Evotec Biologics & Biocon Biologics sign licensing deal for a biosimilar asset

Press ReleaseOctober 19, 2019

Biocon Biologics in-licenses an early-stage biosimilar asset, will undertake development, manufacturing and commercialisation under its own label. Just – Evotec Biologics has received a license…

Learn more

Evotec completes acquisition of Just Biotherapeutics

Press ReleaseJuly 3, 2019

Acquisition extends Evotec’s multimodality offering, with integrated solutions for small molecules and biologics. Expands Evotec’s US footprint in Seattle and machine learning capabilities. Deal value…

Learn more

Just Biotherapeutics and Teva enter an agreement for the design and development of a high productivity (HP) biomanufacturing process

Press ReleaseJune 28, 2019

Just Biotherapeutics, Inc. (“Just.Bio”), an integrated design company focused on technologies for accelerating the development and manufacture of biotherapeutics, announced today that they have entered…

Learn more

Evotec jump-starts biologics with acquisition of Just Biotherapeutics

Press ReleaseMay 20, 2019

Evotec’s offering of integrated solutions extended to biologics. Addition of longstanding biologics expertise based on key talents, innovative ML (machine learning) driven technologies and sophisticated…

Learn more
12
innovation by design
North America
Just – Evotec Biologics, Inc.
401 Terry Avenue
Seattle, WA 98109
+1 206-651-5094
Europe + International
Just – Evotec Biologics
Business Development
info@evotec.com

Find us on:

Twitter page opens in new windowLinkedin page opens in new windowMail page opens in new window
© 2022 Just – Evotec Biologics
  • Contact
  • Imprint
  • Privacy Policy
  • Legal notice
footer menu
Go to Top